TrialMolecular cancer therapeutics2023

A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE).

Elizabeth Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.